Cxcl9 - chemokine (C-X-C motif) ligand 9 Gene

Also Known as CMK; Mig; MuMIG; Scyb9; crg-10

Species: Mus musculus

Gene Type: protein coding
Gene ID: 17329

Summary

Predicted to enable CXCR3 Chemokine Receptor binding activity and chemokine activity. Acts upstream of or within several processes, including defense response to virus; positive regulation of myoblast differentiation; and positive regulation of myoblast fusion. Located in external side of plasma membrane and extracellular space. Is expressed in central nervous system; retina; stomach; testis; and Thymus. Orthologous to human CXCL9 (C-X-C motif chemokine ligand 9). [provided by Alliance of Genome Resources, Apr 2022]

Cxcl9 Products (1)

mRNA Protein Name
NM_008599.4 NP_032625.2 C-X-C motif chemokine 9 precursor

Gene Ontology

  • Biological Process
  • Cellular Component
Biological Process GO Annotation Evidence References Source
acts upstream of or within defense response to virus IDA
IDA: Inferred from direct assay
17277142 MGI
acts upstream of or within positive regulation of myoblast differentiation IMP
IMP: Inferred from mutant phenotype
23844157 MGI
acts upstream of or within positive regulation of myoblast fusion IMP
IMP: Inferred from mutant phenotype
23844157 MGI
acts upstream of or within response to bacterium IEP
IEP: Inferred from expression pattern
23012479 MGI
Cellular Component GO Annotation Evidence References Source
located in external side of plasma membrane IDA
IDA: Inferred from direct assay
19008373 MGI
located in extracellular space IDA
IDA: Inferred from direct assay
17277142 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

C-X-C motif chemokine 9

  • M119

  • gamma interferon-induced monokine

  • monokine induced by gamma interferon

  • monokine induced by interferon-gamma

  • protein m119

  • small inducible cytokine B subfamily (Cys-X-Cys), member 9

  • small-inducible cytokine B9

Recombinant Cxcl9 Proteins

Cat. No. Product Name Accession Purity
HY-P70008 MIG/CXCL9 Protein, Mouse (HEK293, His) P18340 (T22-T126) ≥ 95%, as determined by reducing SDS-PAGE.

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-N18667 Centella asiatica extract Inhibitor / Phase 4
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P991610 S-095029 Inhibitor / Phase 2

Pre-clinical Phase

Bioactive Molecules (10)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-N7688 Regaloside B Inhibitor 99.90% Unkown
HY-165428 SCH-900875 Inhibitor 98.16% Unkown
HY-P10887 Pegevongitide 99.6% Unkown
HY-162415 CSF1R-IN-22 / Unkown
HY-168971 Paeoniflorin-6′-O-benzene sulfonate / Unkown
HY-181877 IHCH-3185 / Unkown
HY-P10301 CXCL9(74-103) / Unkown
HY-RS03396 CXCL9 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W505771 Seselin Inhibitor 99.55% Unkown
HY-167884 PF-1367550 Inhibitor / Unkown
Inhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990255 Anti-Mouse CXCL9/MIG Antibody (MIG-2F5.5) Inhibitor 99.47% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Cxcl9 NCBI NCBI:4283